I have another question.
The minister talked about health care innovation being a priority area. I wonder if pharmacare is seen as an innovation. A national pharmacare strategy was seen as an innovation in the 2004 accord. Nothing has transpired in that national pharmacare strategy. We now find that many patients don't have any access because of cost. They cannot afford to pay for their drugs for chronic or terminal diseases in the home or in the community.
Why has nothing been done about setting that kind of pharmacare strategy, specifically looking at decreasing the cost to patients?